Limited association of the 2988G>A single nucleotide polymorphism with CYP2D6*41 in black subjects

被引：25

作者：

Gaedigk, A ^{[1
]}

Ndjountché, L

Leeder, JS

Bradford, LD

机构：

[1] Childrens Mercy Hosp & Clin, Div Clin Pharmacol & Expt Therapeut, Kansas City, MO USA

[2] Morehouse Sch Med, Atlanta, GA 30310 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2005年 / 77卷 / 03期

关键词：

D O I：

10.1016/j.clpt.2004.10.014

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：228 / 230

页数：3

共 5 条

[1] CYP2D6 poor metabolizer status can be ruled out by a single genotyping assay for the-1584G promoter polymorphism [J].

Gaedigk, A ;

Ryder, DL ;

Bradford, LD ;

Lceder, JS .

CLINICAL CHEMISTRY, 2003, 49 (06) :1008-1011

[2] Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans [J].

Gaedigk, A ;

Bradford, LD ;

Marcucci, KA ;

Leeder, JS .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (01) :76-89

[3] Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data [J].

Gaedigk, A ;

Gotschall, RR ;

Forbes, NS ;

Simon, SD ;

Kearns, GL ;

Leeder, JS .

PHARMACOGENETICS, 1999, 9 (06) :669-682

[4]

NALLA R, AUTOMATED SPLICE SIT

[5] A novel intronic mutation, 2988G>A, with high predictivity for impaired function of cytochrome P450 2D6 in white subjects [J].

Raimundo, S ;

Toscano, C ;

Klein, K ;

Fischer, J ;

Griese, EU ;

Eichelbaum, M ;

Schwab, M ;

Zanger, UM .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (02) :128-138

← 1 →

Limited association of the 2988G&gt;A single nucleotide polymorphism with CYP2D6*41 in black subjects

Limited association of the 2988G>A single nucleotide polymorphism with CYP2D6*41 in black subjects